Cover Image
市場調查報告書

Levothyroxine的中國市場分析

Investigation Report on China Levothyroxine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333485
出版日期 內容資訊 英文 20 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Levothyroxine的中國市場分析 Investigation Report on China Levothyroxine Market, 2010-2019
出版日期: 2015年06月18日 內容資訊: 英文 20 Pages
簡介

甲狀腺荷爾蒙 (TH) 對促進生後不滿5個月的嬰兒的成長發揮最大的效果。反過來說,因為腦垂體無法像TH那樣供給生長激素 (GH) ,先天性甲狀腺荷爾蒙缺乏等的情況下,就會發生呆小症。Levothyroxine用於治療先天性的甲狀腺機能低下症 (呆小症) ,其他也可利用在單純甲狀腺瘤和慢性淋巴性甲狀腺炎的抑制療法,甲狀腺癌症的治療後的抑制療法,甲狀腺功能亢進症的阻斷試驗等。中國國內的Levothyroxine的市場規模,從2005年的1500萬人民幣,每年以17.5%的年複合成長率(CAGR) 成長,2014年達6351萬人民幣。

本報告提供中國的Levothyroxine的市場相關分析、整體市場規模和國內價格趨勢、各企業、各投藥形態的市場佔有率、主要製造商簡介、今後的市場趨勢預測等調查評估。

第1章 Levothyroxine的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Levothyroxine市場概況

  • 中國國內的Levothyroxine專利的申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Levothyroxine銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Levothyroxine市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Levothyroxine市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Levothyroxine的醫院用標準價格

  • China Associated Pharmaceutical (商標名:Jiaheng)
  • Berlin-Chemie AG (德國) (商標名:Letrox)
  • Merck (德國) (商標名:Euthyrox)

第7章 中國國內的Levothyroxine的主要製造商

  • Merck (德國)
  • China Associated Pharmaceutical
  • Berlin-Chemie AG (德國)

第8章 中國的Levothyroxine市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506227

Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones mainly promote the growth and development of bones, brain and reproductive organs, even the growth hormone (GH) of pipuitary gland can't work. Besides, pipuitary gland will produce less GH if there is a lack of thyroid hormones. Therefore, cretinism is caused by congenital TH deficiency. Cretinism patients featuring stagnated bone growth and short stature, have abnormal proportion of upper body to lower body with upper body being longer than ordinary people.

Levothyroxine is used for the treatment of congenital hypothyroidism (cretinism) and the long-term replacement treatment of hypothyroidism caused by various reasons. It can also be used in the suppressive therapy for simple goiter, chronic lymphatic thyroiditis, the suppressive therapy after thyroid cancer and the hyperthyroidism inhibition test.

Levothyroxine has become the best-selling drug after entering various countries. It develops fast after entering China with annual sales value rising from less than CNY 15 million in 2005 to CNY 63.51 million in 2014 and CAGR during this period reaching up to 17.5%. Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck has the largest share of about 95% for sales value in 2014.

The market size of levothyroxine in China is expected to keep growing in the next few years.

Readers can get at least the following information from this report:

  • market size of levothyroxine in China
  • competitive landscape of levothyroxine in Chinese market
  • price of levothyroxine made by different enterprises in China
  • market outlook of levothyroxine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of drugs for regulating endocrine metabolism
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

Table of Contents

1. Related Concepts of Levothyroxine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Levothyroxine in China

  • 2.1. Patent and Approval Status of Levothyroxine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Levothyroxine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Levothyroxine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Levothyroxine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Levothyroxine in China in 2014

  • 6.1. China Associated Pharmaceutical (Trade Name: Jiaheng)
  • 6.2. Berlin-Chemie AG (Germany) (Trade Name: Letrox)
  • 6.3. Merck (Germany) (Trade Name: Euthyrox)

7. Major Manufacturers of Levothyroxine in Chinese Market, 2010-2014

  • 7.1. Merck (Germany)
  • 7.2. China Associated Pharmaceutical
  • 7.3. Berlin-Chemie AG (Germany)

8. Market Outlook of Levothyroxine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Levothyroxine in China
  • Chart Sales Status of Levothyroxine in China, 2010-2014
  • Chart Sales Value of Levothyroxine in China, 2010-2014
  • Chart Sales Salue of Levothyroxine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Levothyroxine in China, 2010-2014
  • Chart Market Share of TOP3 Manufacturers of Levothyroxine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Levothyroxine Made by Merck (Germany) in China, 2010-2014
  • Chart Sales Value and Market Share of Levothyroxine Made by Berlin-Chemie AG (Germany) in China, 2010-2014
  • Chart Sales Value and Market Share of Levothyroxine Made by China Associated in China, 2010-2014
  • Chart Price of Levothyroxine Made by China Associated Pharmaceutical in Some Chinese Cities in 2014
  • Chart Price of Levothyroxine Made by Berlin-Chemie AG (Germany) in Some Chinese Cities in 2014
  • Chart Price of Levothyroxine Made by Merck (Germany) in Some Chinese Cities in 2014
Back to Top